Don't take this personally but I wouldn't trust someone who valued RAC at $600M from just starting Ph1 clinical trial for their only IP to value IMU's multiple advanced IP. The CN will be at 4.75c provided the clinical trial updates for VAXINIA and especially OASIS are positive, yes "will" and not "could" and if you thought IMU's CR was poor you should look at ALA (CD19 IP) who just did a CR last week.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.2¢ | $267.3K | 20.57M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 788815 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 13241534 | 29 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |